| A novel c-Jun N-terminal kinase (JNK)-binding protein WDR62 is recruited to stress granules and mediates a nonclassical JNK activation T Wasserman, K Katsenelson, S Daniliuc, T Hasin, M Choder, A Aronheim Molecular biology of the cell 21 (1), 117-130, 2010 | 94 | 2010 |
| Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis syndrome is caused by a POC1A mutation O Sarig, S Nahum, D Rapaport, A Ishida-Yamamoto, D Fuchs-Telem, ... The American Journal of Human Genetics 91 (2), 337-342, 2012 | 73 | 2012 |
| Infantile mitochondrial hepatopathy is a cardinal feature of MEGDEL syndrome (3‐methylglutaconic aciduria type IV with sensorineural deafness, encephalopathy and Leigh‐like … O Sarig, D Goldsher, J Nousbeck, D Fuchs‐Telem, K Cohen‐Katsenelson, ... American journal of medical genetics Part A 161 (9), 2204-2215, 2013 | 57 | 2013 |
| The PHLPP2 phosphatase is a druggable driver of prostate cancer progression DG Nowak, KC Katsenelson, KE Watrud, M Chen, G Mathew, ... Journal of Cell Biology 218 (6), 1943-1957, 2019 | 43 | 2019 |
| Docking interactions of the JNK scaffold protein WDR62 K Cohen-Katsenelson, T Wasserman, S Khateb, AJ Whitmarsh, ... Biochemical Journal 439 (3), 381-392, 2011 | 39 | 2011 |
| Pleckstrin homology domain leucine-rich repeat protein phosphatases set the amplitude of receptor tyrosine kinase output G Reyes, M Niederst, K Cohen-Katsenelson, JD Stender, MT Kunkel, ... Proceedings of the National Academy of Sciences 111 (38), E3957-E3965, 2014 | 33 | 2014 |
| PHLPP1 counter-regulates STAT1-mediated inflammatory signaling K Cohen Katsenelson, JD Stender, AT Kawashima, G Lorden, ... Elife 8, e48609, 2019 | 30 | 2019 |
| Hyperbaric oxygen pretreatment reduces the incidence of decompression sickness in rats K Katsenelson, Y Arieli, A Abramovich, M Feinsod, R Arieli European journal of applied physiology 101, 571-576, 2007 | 30 | 2007 |
| Identification and analysis of a novel dimerization domain shared by various members of c-Jun N-terminal kinase (JNK) scaffold proteins K Cohen-Katsenelson, T Wasserman, I Darlyuk-Saadon, A Rabner, ... Journal of Biological Chemistry 288 (10), 7294-7304, 2013 | 24 | 2013 |
| PHLPPing the script: emerging roles of PHLPP phosphatases in cell signaling TR Baffi, K Cohen-Katsenelson, AC Newton Annual review of pharmacology and toxicology 61 (1), 723-743, 2021 | 22 | 2021 |
| Hyperbaric oxygen pretreatment according to the gas micronuclei denucleation hypothesis reduces neurologic deficit in decompression sickness in rats K Katsenelson, R Arieli, Y Arieli, A Abramovich, M Feinsod, D Tal Journal of Applied Physiology 107 (2), 558-563, 2009 | 20 | 2009 |
| Oxygen pretreatment as protection against decompression sickness in rats: pressure and time necessary for hypothesized denucleation and renucleation R Arieli, E Boaron, Y Arieli, A Abramovich, K Katsenelson European journal of applied physiology 111, 997-1005, 2011 | 14 | 2011 |
| Bubble reduction after decompression in the prawn Palaemon elegans by pretreatment with hyperbaric oxygen Y Arieli, K Katsenelson, R Arieli Undersea and Hyperbaric Medicine 34 (5), 369, 2007 | 12 | 2007 |
| The association of the JNK scaffold protein, WDR62, with the mixed lineage kinase 3, MLK3 M Hadad, S Aviram, I Darlyuk-Saadon, K Cohen-Katsenelson, ... MAP Kinase 4 (1), 2015 | 6 | 2015 |
| The tumor suppressor phosphatase PHLPP1 suppresses inflammatory signaling by regulating the phosphorylation state and activity of STAT1 KC Katsenelson, JD Stender, S Uchiyama, V Nizet, CK Glass, AC Newton The FASEB Journal 32, 648.11-648.11, 2018 | | 2018 |
| The Protein Phosphatase PHLPP1 Suppresses Insulin Signaling and Inflammation in Mouse Model G Lorden, S Skovsų, M Riopel, K Cohen‐Katsenelson, JD Johnson, ... The FASEB Journal 32, 670.55-670.55, 2018 | | 2018 |
| Tumor suppressor phosphatase PHLPP1 regulates transcription factor activity and gene expression in inflammation KC Katsenelson, JD Stender, CK Glass, AC Newton Cancer Research 77 (13_Supplement), 4488-4488, 2017 | | 2017 |
| Tumor Suppressor Phosphatase PHLPP Regulates Gene Expression Through Suppression of Transcription Factor Activation KC Katsenelson, JD Stender, C Glass, AC Newton The FASEB Journal 30, 1055.8-1055.8, 2016 | | 2016 |
| PHLPP phosphatases are master regulators of cellular receptor tyrosine kinase levels (802.19) K Cohen Katsenelson, G Reyes, M Niederst, M Chen, D Nowak, M Kunkel, ... The FASEB Journal 28, 802.19, 2014 | | 2014 |
| Li Qiaoli, 6 Ksenya Cohen-Katsenelson, 2 Ronen Spiegel, 2, 7 Janna Nousbeck, Shirli Israeli, Zvi-Uri Borochowitz, 2, 8 Gilly Padalon-Brauch, Jouni Uitto, 6 Mia Horowitz, 3 … O Sarig, S Nahum, D Rapaport, A Ishida-Yamamoto, D Fuchs-Telem The American Journal of Human Genetics 91, 1-6, 2012 | | 2012 |
